SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-302123
Filing Date
2018-10-18
Accepted
2018-10-18 17:27:04
Documents
3
Period of Report
2018-10-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d636249d8k.htm 8-K 15429
2 EX-99.1 d636249dex991.htm EX-99.1 9844
3 GRAPHIC g636249g51d74.jpg GRAPHIC 5528
  Complete submission text file 0001193125-18-302123.txt   34134
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38653 | Film No.: 181128959
SIC: 2834 Pharmaceutical Preparations